Escitalopram and amitriptyline lengthened QTc most; antidepressants were not linked to early cardiac events

Design

Individual participant data network meta-regression of double-blind randomised trials

Population

35 trials, 8,679 adults with major depression (MACE analysis: 139 trials, 52,398)

Primary outcome

Change in QTc (Fridericia) over 8 weeks

Effect

Escitalopram +8.7 ms (1.6 to 15.8); amitriptyline +5.3 ms (0.8 to 9.8); no excess early MACE

An individual-participant network meta-regression pooled 35 double-blind trials with QTc data on 8,679 adults with major depression, covering ten antidepressants and placebo. It modelled QTc change against baseline QTc, age, sex, BMI, serum potassium and eGFR, factors that matter in kidney patients.

Over the first eight weeks, escitalopram lengthened QTc by 8.7 ms (95% credible interval 1.6 to 15.8) and amitriptyline by 5.3 ms (0.8 to 9.8) compared with placebo. After accounting for risk factors, amitriptyline and escitalopram were most often associated with the largest QTc prolongation, and venlafaxine and vortioxetine with the smallest. Effects varied considerably between individuals, especially for escitalopram, fluoxetine and mirtazapine. Across 139 trials and 52,398 participants, antidepressants were not associated with more early major cardiac events or non-suicidal deaths.

Trial populations usually exclude people with advanced CKD, dialysis or marked electrolyte disturbance, so the absolute risk in kidney patients may be higher. The practical message is to choose an antidepressant with QT risk in mind when potassium, magnesium or other QT-prolonging drugs are an issue, not to withhold treatment for depression.

• Consider QT risk when choosing an antidepressant for patients with CKD or on dialysis
• Be cautious with escitalopram and amitriptyline when baseline QTc is long or electrolytes are unstable
• Check potassium, magnesium and a baseline ECG before starting a QT-prolonging antidepressant in high-risk patients
• Review other QT-prolonging drugs on the list, such as some antiemetics and antibiotics
• Do not withhold depression treatment because of QT concerns; choose and monitor instead

Why it matters

Kidney patients often combine low potassium or magnesium, dialysis shifts and other QT drugs, so the choice of antidepressant carries more weight.

Don't overread it

Trials rarely included people with advanced CKD or on dialysis, so risk in those groups is extrapolated.

The statistics, in plain English

An 8.7 ms average rise is modest for most people but can matter when QTc is already long. The credible interval for escitalopram (1.6 to 15.8 ms) is wide, reflecting variable responses between individuals.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.